Ginger on the Breathe label
The current Breathe label lists ginger (Zingiber officinale) root in a 550 mg proprietary blend. The amount of ginger itself is not separately disclosed.
What ginger has actually been studied for
NCCIH summarizes a substantial body of human research on ginger, especially for nausea and vomiting in certain settings. Other proposed uses have less certain evidence. This distinction is important: a familiar botanical can have real research without that research supporting every marketing claim attached to it.
Can ginger evidence prove a respiratory benefit?
No finished-product conclusion should be drawn from ginger studies alone. Even if a botanical has laboratory anti-inflammatory findings, a respiratory outcome in humans would require appropriately designed clinical research using a relevant preparation and dose.
This site therefore describes ginger as a labeled ingredient and summarizes independent background research without claiming that ginger makes Breathe a treatment for cough, COPD, asthma, infection or mucus-related disease.
Ginger safety considerations
NCCIH notes that ginger can cause abdominal discomfort, heartburn, diarrhea and mouth or throat irritation in some people. Because herbs may interact with medicines, people taking medication or managing a medical condition should discuss supplement use with a clinician.
References & further reading
- FDA — Dietary Supplement Labeling Guide — background on Supplement Facts and proprietary blends
- NCCIH — Ginger — evidence and safety overview